These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 20826181)

  • 21. Synthesis of substituted pyrimidines as corticotropin releasing factor (CRF) receptor ligands.
    Kuppast B; Spyridaki K; Liapakis G; Fahmy H
    Eur J Med Chem; 2014 May; 78():1-9. PubMed ID: 24675175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective corticotropin-releasing factor 1 receptor antagonist E2508 has potent antidepressant-like and anxiolytic-like properties in rodent models.
    Taguchi R; Shikata K; Furuya Y; Ino M; Shin K; Shibata H
    Behav Brain Res; 2016 Oct; 312():138-47. PubMed ID: 27297028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stress responsive neurohormones in depression and anxiety.
    Ströhle A; Holsboer F
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S207-14. PubMed ID: 14677081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central CRH system in depression and anxiety--evidence from clinical studies with CRH1 receptor antagonists.
    Holsboer F; Ising M
    Eur J Pharmacol; 2008 Apr; 583(2-3):350-7. PubMed ID: 18272149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Corticotrophin-releasing factor 1 activation in the central amygdale and visceral hyperalgesia.
    Taché Y
    Neurogastroenterol Motil; 2015 Jan; 27(1):1-6. PubMed ID: 25557223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anxiolytic-like effects of the corticotropin-releasing factor1 (CRF1) antagonist DMP904 [4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1,5-a]-pyrimidine] administered acutely or chronically at doses occupying central CRF1 receptors in rats.
    Lelas S; Wong H; Li YW; Heman KL; Ward KA; Zeller KL; Sieracki KK; Polino JL; Godonis HE; Ren SX; Yan XX; Arneric SP; Robertson DW; Hartig PR; Grossman S; Trainor GL; Taub RA; Zaczek R; Gilligan PJ; McElroy JF
    J Pharmacol Exp Ther; 2004 Apr; 309(1):293-302. PubMed ID: 14742750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alterations in the central CRF system of two different rat models of comorbid depression and functional gastrointestinal disorders.
    Bravo JA; Dinan TG; Cryan JF
    Int J Neuropsychopharmacol; 2011 Jun; 14(5):666-83. PubMed ID: 20860876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety.
    Holsboer F
    J Psychiatr Res; 1999; 33(3):181-214. PubMed ID: 10367986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent advances with the CRF1 receptor: design of small molecule inhibitors, receptor subtypes and clinical indications.
    McCarthy JR; Heinrichs SC; Grigoriadis DE
    Curr Pharm Des; 1999 May; 5(5):289-315. PubMed ID: 10213797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The corticotropin-releasing factor (CRF)(1) receptor antagonists CP154,526 and DMP695 inhibit light-induced phase advances of hamster circadian activity rhythms.
    Gannon RL; Millan MJ
    Brain Res; 2006 Apr; 1083(1):96-102. PubMed ID: 16551464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The neuroendocrinology of stress and the pathophysiology and therapy of depression and anxiety].
    Ströhle A
    Nervenarzt; 2003 Mar; 74(3):279-91; quiz 292. PubMed ID: 12627245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The vasopressin V1b receptor as a therapeutic target in stress-related disorders.
    Griebel G; Simiand J; Stemmelin J; Gal CS; Steinberg R
    Curr Drug Targets CNS Neurol Disord; 2003 Jun; 2(3):191-200. PubMed ID: 12769799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corticotropin-releasing factor (CRF) sensitization of ethanol withdrawal-induced anxiety-like behavior is brain site specific and mediated by CRF-1 receptors: relation to stress-induced sensitization.
    Huang MM; Overstreet DH; Knapp DJ; Angel R; Wills TA; Navarro M; Rivier J; Vale W; Breese GR
    J Pharmacol Exp Ther; 2010 Jan; 332(1):298-307. PubMed ID: 19843974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRF receptor type 1 (but not type 2) located within the amygdala plays a role in the modulation of anxiety in mice exposed to the elevated plus maze.
    Cipriano AC; Gomes KS; Nunes-de-Souza RL
    Horm Behav; 2016 May; 81():59-67. PubMed ID: 27060334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of the CRF
    Wróbel A; Serefko A; Szopa A; Rojek K; Poleszak E; Skalicka-Woźniak K; Dudka J
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Aug; 390(8):769-774. PubMed ID: 28429110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of CRF
    Tanaka M; Tomimatsu Y; Sakimura K; Ootani Y; Sako Y; Kojima T; Aso K; Yano T; Hirai K
    Peptides; 2017 Sep; 95():40-50. PubMed ID: 28689880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New directions in the development of antidepressants: the interface of neurobiology and psychiatry.
    Nemeroff CB
    Hum Psychopharmacol; 2002 Jun; 17 Suppl 1():S13-6. PubMed ID: 12404664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vasopressin in health and disease with a focus on affective disorders.
    Zelena D
    Cent Nerv Syst Agents Med Chem; 2012 Dec; 12(4):286-303. PubMed ID: 22954353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corticotrophin releasing factor receptor 1 antagonists prevent chronic stress-induced behavioral changes and synapse loss in aged rats.
    Dong H; Keegan JM; Hong E; Gallardo C; Montalvo-Ortiz J; Wang B; Rice KC; Csernansky J
    Psychoneuroendocrinology; 2018 Apr; 90():92-101. PubMed ID: 29477954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Behavioral, biological, and chemical perspectives on targeting CRF(1) receptor antagonists to treat alcoholism.
    Zorrilla EP; Heilig M; de Wit H; Shaham Y
    Drug Alcohol Depend; 2013 Mar; 128(3):175-86. PubMed ID: 23294766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.